Hemab Therapeutics Holdings Inc (COAG) Price Prediction & Forecast

$44.840

-4.215 (-9.40%)At close

Price Predictions

1-Day Price Prediction

-1.64%

1-Week Prediction

-4.70%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

COAG Prediction & Forecast by Similar Chart Analysis

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $44.10 (-1.64%). The 1-week path is $42.73 (-4.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Hemab Therapeutics Holdings Inc Stock?

Currently, Hemab Therapeutics (COAG) is trading at $44.84, significantly below the average analyst price target of $60, indicating potential upside. However, the stock has a low RSI of 29.128, suggesting it is oversold, but it also reported a wider Q2 loss of $24.2 million, which raises concerns about its financial health. Therefore, while there is potential for recovery, the current financial losses and market volatility suggest a cautious approach.